- Back to menuPrices
- Back to menuResearch
- Back to menuConsensus
- Back to menu
- Back to menu
- Back to menu
- Back to menuWebinars & Events
FM Clip
Pinning FTX Collapse on Ex-Alameda Research CEO Is a 'Very Classic Defense Move,' Lawyer Says
Former Alameda Research CEO Caroline Ellison is scheduled to be the next witness to testify in FTX founder Sam Bankman-Fried's trial. Lowenstein Sandler LLP partner Rachel Maimin, who specializes in white collar criminal defense, discusses what to expect after the defense assigned some of the blame to Ellison during the opening arguments.

Anthony Scaramucci: Watching Sam Bankman-Fried's Trial Unfold Is 'Heartbreaking'
SkyBridge Capital founder and managing partner Anthony Scaramucci explains why it has been "heartbreaking" watching FTX founder Sam Bankman-Fried's trial unfold. Plus, Scaramucci shares insights on how the case could impact the broader crypto industry. "It hurts the reputation of crypto investing, Web3...the whole thought of where we could go from a technical innovation point of view," he added.

Anthony Scaramucci Says the SBF Trial 'Hurts' Crypto's Reputation
SkyBridge Capital founder and managing partner Anthony Scaramucci discusses his take on FTX founder Sam Bankman-Fried's latest legal developments. Scaramucci said watching the trial unfold has "been absolutely heartbreaking." Plus, his reaction to "Going Infinite" author Michael Lewis' portrayal of Bankman-Fried in his latest book and what the future of crypto could look like.

Sam Bankman-Fried's Trial Enters Week 2: Here’s What to Expect
The trial for FTX founder Sam Bankman-Fried is entering its second week. CoinDesk's global policy and regulation managing editor Nikhilesh De discusses what to expect in the coming days, as former Alameda Research CEO Caroline Ellison is set to testify as soon as Tuesday.

FTX Bankruptcy Claims Market Is 'Extremely Active,' 117 Partners CEO Says
117 Partners CEO and founder Thomas Braziel compares the market activity for FTX's bankruptcy claims versus other bankrupt crypto exchanges, like Celsius and Voyager. "Every distressed firm and their brother wants to be involved in FTX versus the other dockets," Braziel said.

Ethereum Network 'Remains the Place to Operate as a Criminal,' Immunefi CEO Says
A new report from Immunefi, which is a bug bounty and security services platform for Web3, found that more than $1 billion was lost in crypto this year and more than $600 million was lost last quarter. Immunefi Founder and CEO Mitchell Amador discusses the details of the report and the outlook for DeFi.

Crypto Traders 'Will Flock' to Small Cap Tokens When Bull Market Returns: Strategist
Bitcoin (BTC)'s price is retreating slightly Friday, hovering around $27,500 after 336,000 jobs were added last month in the U.S. MarketVector Indexes digital asset product strategist Martin Leinweber discusses his crypto markets analysis, along with insights into the sector's performance since September and outlook on large cap tokens.

Anthropic's Growing Value Is a 'Fantastic Turn of Events' For FTX Creditors: 117 Partners CEO
OpenAI rival Anthropic's growing value is sparking hope for some FTX creditors that they will be made whole. FTX and Alameda Research previously invested $500M in the startup, according to Bloomberg. 117 Partners CEO and founder Thomas Braziel discusses what this means for the FTX ecosystem as Sam Bankman-Fried's trial is underway.

Sam Bankman-Fried's Trial: A Look Inside the Courtroom
CoinDesk's global policy and regulation managing editor Nikhilesh De shares the details of what it's been like inside the courtroom for FTX founder Sam Bankman-Fried's ongoing trial. Plus, insights on testimonies from witnesses including the exchange's co-founder Gary Wang.

Citi Developing Token Services for Institutional Clients
Citi announced recently it's developing a tokenization service for cash management and trade finance for institutional clients using blockchain technology and smart contracts. Ryan Rugg and Stephen Randall from Citi's Treasury and Trade Solutions discuss the move and what kind of interest they are seeing from institutional clients.
